Course Content
Clinician Perspectives to Drive Radionuclide Theranostic Innovation
0/1
Clinician Perspectives to Drive Radionuclide Theranostic Innovation
21:40
Radionuclide Theranostics: Expanding the Physician’s Therapeutic Arsenal
0/2
Abstract
Radionuclide Theranostics: Expanding the Physician’s Therapeutic Arsenal
14:26
Supplying the Source: Isotope Production for Radiotheranostic Success
0/2
Abstract
Supplying the Source: Isotope Production for Radiotheranostic Success
19:09
Status of theranostic radionuclides production in Canada: TRIUMF experience
0/2
Abstract
Status of theranostic radionuclides production in Canada: TRIUMF experience
19:05
Bridging the Gap: Aligning Preclinical Targets with Clinical Realities
0/2
Abstract
Bridging the Gap: Aligning Preclinical Targets with Clinical Realities
13:19
Keynote Presentation
0/1
Theranostics – Precision Medicine in Cancer Treatment
32:30
Radiotheranostics: Navigating Developmental, Commercial, and Clinical Hurdles: Academic and Industry Challenges
Talk Summary:
This session explores strategies to bridge the divide between preclinical research and clinical realities. Experts will discuss strategies to reconcile divergences between preclinical models and patient populations, addressing factors like biodistribution, dosimetry, and therapeutic windows. The goal is to identify key considerations for accelerating the development of clinically relevant radionuclide theranostics.

Author

Riccardo Canevari, College Degree in Pharmacy and Chemistry
CEO
Radiopharm Theranostics
Previous
Next
0% Complete